Cabaletta Bio (CABA) Change in Cash (2018 - 2025)
Cabaletta Bio's quarterly Change in Cash came in at $22.8 million in Q4 2025, up 442.7% year-on-year from $4.2 million in Q4 2024, and up 126.67% quarter-over-quarter from -$85.4 million in Q3 2025.
Cabaletta Bio has reported Change in Cash for 8 years, with the latest figure at $22.8 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash rose 442.7% year-over-year to $22.8 million; the trailing twelve-month figure through Dec 2025 stood at -$81.0 million (down 176.61% YoY), and the FY2025 full-year result was -$81.0 million, down 176.61% from the prior year.
- Change in Cash for Q4 2025 stood at $22.8 million, up from -$85.4 million in the prior quarter.
- The five-year high for Change in Cash was $77.7 million in Q4 2023, with the low at -$85.4 million in Q3 2025.
- Average Change in Cash over 5 years is -$922350.0, with a median of $2.8 million recorded in 2021.
- Year-over-year, Change in Cash soared 649.01% in 2021 and slumped 1409.37% in 2022.
- Tracing CABA's Change in Cash over 5 years: stood at $4.0 million in 2021, then jumped by 416.0% to $20.4 million in 2022, then soared by 280.24% to $77.7 million in 2023, then slumped by 108.55% to -$6.6 million in 2024, then soared by 442.7% to $22.8 million in 2025.
- The last three Change in Cash figures came in at $22.8 million (Q4 2025), -$85.4 million (Q3 2025), and $13.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 22.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.78 Mn |
| Sep 30, 2025 | -85.41 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | -32.13 Mn |
| Dec 31, 2024 | -6.65 Mn |
| Sep 30, 2024 | -8.01 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | -17.95 Mn |
| Dec 31, 2023 | 77.74 Mn |
| Sep 30, 2023 | -12.57 Mn |
| Jun 30, 2023 | 34.23 Mn |
| Mar 31, 2023 | 12.24 Mn |
| Dec 31, 2022 | 20.44 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | -12.38 Mn |
| Mar 31, 2022 | -62.67 Mn |
| Dec 31, 2021 | 3.96 Mn |
| Sep 30, 2021 | 18.77 Mn |
| Jun 30, 2021 | 2.22 Mn |
| Mar 31, 2021 | -4.15 Mn |
| Dec 31, 2020 | -7.25 Mn |
| Sep 30, 2020 | -3.42 Mn |
| Jun 30, 2020 | -18.91 Mn |
| Mar 31, 2020 | -5.20 Mn |
| Dec 31, 2019 | 65.16 Mn |
| Sep 30, 2019 | -4.22 Mn |
| Jun 30, 2019 | -4.98 Mn |
| Mar 31, 2019 | 47.22 Mn |
| Dec 31, 2018 | 23.23 Mn |